AI/ML Innovations Inc. (CSE: $AIML) turns AI & ML into clearer biometrics and smarter healthcare. Investing in digital-health tech that uplifts lives worldwide.
Toronto, Canada
Joined November 2023
- Tweets364
- Following9
- Followers656
- Likes262
Pinned Tweet
$AIML has been granted U.S. Patent No. 12,465,266 for its ECG signal-processing neural network - covering denoising, wave analysis & rhythm detection.
With no prior art, this patent reinforces AIML’s IP strength in biometric signal processing
Full PR: accessnewswire.com/newsroom/…
New look at theneuralcloud.com - including a Digital Therapeutics section on where MaxYield fits: drug discovery, cardiotoxicology, biomarkers, trials, pre-clinical. The recording you see is what was captured.
For research and investigational use: theneuralcloud.com/digital-t…
$AIML appoints Lynn Chapman as CFO. Mr. Chapman is a CPA with more than 15 years of financial and managerial experience, providing business management, accounting, financial reporting and advisory services to public & private companies.
Full PR:
aiml-innovations.com/press-r…
MaxYield™ is entering preclinical cardiac safety. $AIML signs binding term sheet with VetMed Consultants to validate its ECG signal-processing platform in preclinical workflows - phased, gated, built on data integrity and clinical oversight.
aiml-innovations.com/press-r…
$AIML Subsidiary NeuralCloud integrates myPatch® Holter hardware with CardioYield™ software in Ontario pre-regulatory pilots - evaluating signal quality, reporting accuracy & workflow efficiency.
Full Press Release: aiml-innovations.com/press-r…
The $AIML website has a new look - One patented cardiac-AI engine. Three markets.
Plus we added a Newsroom page: Press Releases, our CEO's Substack, The Pulse newsletter, & shareholder videos - all in one feed.
aiml-innovations.com
$AIML launches Quantum Soma, a strategic initiative developed in partnership with @DynexQaaS to advance a contactless quantum biosensing platform, combining Dynex's NV-Diamond quantum sensors with AIML's proprietary MaxYield signal intelligence
Full PR: aiml-innovations.com/press-r…
Our Summer 2026 issue of $AIML's The Pulse is out:
🔹 Ex-FDA reviewer joins NeuralCloud as Head of Regulatory
🔹 ISO 13485 & MDSAP Certification earned
🔹 New AI-ECG patent granted
🔹 2 ECG veterans join to lead Clinical & Over-read Ops
Subscribe here: eepurl.com/je2YGg
Former FDA reviewer joins $AIML. Dr. Mehmet A. Kosoglu appointed Head of Regulatory, bringing 15+ years of FDA, Software as a Medical Device (SaMD) & digital health expertise to lead strategy for AI-powered cardiac technologies MaxYield & CardioYield
Full Press Release: aiml-innovations.com/press-r…
$AIML subsidiary NeuralCloud Solutions to Pilot MaxYield and CardioYield within Island Mobile Cardiology Testing's Holter workflow: measuring agreement, false positives/negatives, signal quality, report quality, turnaround time & technician efficiency
aiml-innovations.com/press-r…
$AIML subsidiary, NeuralCloud, earns ISO 13485 (MDSAP) Certification - establishing an audited quality framework that supports regulatory, clinical & commercialization activities for ECG-focused Software as a Medical Device across multiple jurisdictions.
aiml-innovations.com/press-r…
$AIML subsidiary NeuralCloud Solutions Inc. has been granted another U.S. Patent, covering AI-driven ECG analysis capabilities including denoising, rhythm classification, sample-level labelling, wearable monitoring, and automated reporting.
Full PR: aiml-innovations.com/press-r…
Millions stare at ECG results trying to decode waveforms cardiologists spend years interpreting. False reassurance delays life-saving care. False alarm creates unnecessary anxiety. Why expert interpretation is irreplaceable.
Full Article: linkedin.com/pulse/ecg-basic…
Your heart runs its own neural network command centre - no brain required. The heart's 40,000+ embedded neurons self-regulate rhythm & function independently. Even transplanted hearts self-regulate🫀
Learn More in our latest article: linkedin.com/pulse/your-hear…
🤖 Made with AI
$AIML Subsidiary NeuralCloud Appoints Dale & Nicholas DuBois to lead clinical and overread operations. This brings decades of experience & strengthens governance as its ECG signal-processing technology advances through regulatory review toward future commercialization.
Full PR: aiml-innovations.com/press-r…
The AI ECG analysis market is set to surpass $5B by 2030 at 18% CAGR - arrhythmia detection is the #1 use case, North America leads, and cloud-based AI will capture 56% of market value. Telehealth and ambulatory monitoring are driving the scale.
$AIML
natlawreview.com/press-relea…
🤖 Made with AI
$AIML Appoints Dr. Martin Green to Medical Advisory Board: Founding architect of Canadian cardiac electrophysiology and 45-year ECG authority joins AIML's MAB - extending national clinical coverage to University of Ottawa Heart Institute
Full PR: aiml-innovations.com/press-r…
If you missed April's edition of The Pulse Newsletter, here's the latest from $AIML:
→ Paul Duffy launches the Signal & Noise Series on Substack
→ Baker Heart HRV research partnership
→ MaxYield™ plugs into European ECG platform
→ What does AFib look like on an ECG?